Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.

Nortier E, Boczar MM, Hughes JA, van der Westhuizen JN, Palmer M, Garcia-Prats AJ, van der Laan L, Nielsen JC, Karlsson MO, Carelse A, Courtney I, Draper H, Schaaf HS, Faraj A, Svensson EM, Hesseling AC

Open source

DOI: 10.1093/infdis/jiag381
Published: 2026 Aug 13
Container: The Journal of infectious diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiag381,
  title = {Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.},
  author = {Nortier E and Boczar MM and Hughes JA and van der Westhuizen JN and Palmer M and Garcia-Prats AJ and van der Laan L and Nielsen JC and Karlsson MO and Carelse A and Courtney I and Draper H and Schaaf HS and Faraj A and Svensson EM and Hesseling AC},
  year = {2026},
  journal = {The Journal of infectious diseases},
  doi = {10.1093/infdis/jiag381},
  url = {https://doi.org/10.1093/infdis/jiag381}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.
AU  - Nortier E
AU  - Boczar MM
AU  - Hughes JA
AU  - van der Westhuizen JN
AU  - Palmer M
AU  - Garcia-Prats AJ
AU  - van der Laan L
AU  - Nielsen JC
AU  - Karlsson MO
AU  - Carelse A
AU  - Courtney I
AU  - Draper H
AU  - Schaaf HS
AU  - Faraj A
AU  - Svensson EM
AU  - Hesseling AC
PY  - 2026
JO  - The Journal of infectious diseases
DO  - 10.1093/infdis/jiag381
UR  - https://doi.org/10.1093/infdis/jiag381
ER  -

APA

E, N., MM, B., JA, H., JN, V. D. W., M, P., AJ, G., L, V. D. L., JC, N., MO, K., A, C., I, C., H, D., HS, S., A, F., EM, S., & AC, H. (2026). Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiag381

Source records

pubmed · retrieved 2026-09-25T05:49:28.215Z